Obstructive sleep apnea pretreatment and posttreatment in symptomatic children with congenital craniofacial

Marta Moraleda-Cibrián1,2, Sean P Edwards2, Steven J Kasten3

  • 1Sleep Disorders Center, Department of Neurology, University of Michigan, Ann Arbor, MI.

Insights

Obstructive sleep apnea (OSA) is highly prevalent in children with craniofacial malformations (CFM), with many cases being moderate-to-severe. Residual OSA after treatment is common, indicating a need for ongoing evaluation in this population.

Area of Science:

  • Pediatric Pulmonology
  • Craniofacial Medicine
  • Sleep Medicine

Background:

  • Obstructive sleep symptoms are frequent in children with craniofacial malformations (CFM).
  • Objective data on obstructive sleep apnea (OSA) in this population is limited.
  • Children with CFM often present with complex airway challenges.

Purpose of the Study:

  • To determine the frequency of OSA in symptomatic children with CFM.
  • To assess the severity of OSA in this cohort.
  • To evaluate the effectiveness of treatments for OSA in children with CFM.

Main Methods:

  • Retrospective review of symptomatic children with CFM undergoing polysomnography (PSG).
  • Defined OSA as an apnea/hypopnea index (AHI) ≥ 1; moderate/severe OSA as AHI ≥ 5.
  • Analyzed treatment outcomes for positive airway pressure (PAP) and adenotonsillectomy (AT).

Main Results:

  • 87% of 151 symptomatic children with CFM were diagnosed with OSA; 24% had moderate-to-severe OSA.
  • Syndromic CFM was associated with a higher likelihood of moderate-to-severe OSA (33% vs. 15%).
  • PAP therapy showed a trend towards decreased AHI and improved SpO2, while AT did not yield significant improvements.

Conclusions:

  • The majority of symptomatic children with CFM exhibit objective evidence of OSA, often moderate-to-severe.
  • Many children with CFM may have undiagnosed OSA, necessitating proactive screening.
  • Persistent OSA after treatment is a significant concern in children with CFM.
Abstract